[News Article]Interview of Dr. Jin-San Yoo, CEO of PharmAbcine with informa

14 Jan 2019
Title
Interview of Dr. Jin-San Yoo, CEO of PharmAbcine with informa
Category
News Article


Interview of Dr. Jin-San Yoo, CEO of PharmAbcine with informa


"PharmAbcine's Hopes Rise As Tanibirumab Set For Keytruda Combo Trials"



PharmAbcine CEO Jin-San Yoo talks to Scrip about the company’s overseas clinical trial strategy, pipeline assets, and ambitions for lead candidate TTAC-0001, which the company sees as superior to Avastin. The Korean biotech, which is engaged in various global collaborations on its investigative antibody drugs, hopes that tie-ups can lead to bigger outcomes going forward.


 Please check  PDF file for details.




     2F, Research Building 2, 70,

     Yuseong-daero 1689 beon-gil,
     Yuseong-gu, Daejeon, 34047, Republic of Korea


     HQ +82-42-863-2017 

     R&D Center +82-42-861-2017

     Investor Relations +70-4294-6097 

     FAX +82-42-863-2080 


     COPYRIGHT BY PharmAbcine Inc.

     ALL RIGHTS RESERVE